PharmaGap Inc. is a biotechnology company with a core focus discovering and developing novel therapeutic drugs for the treatment of cancer. Founded in 1999, the Company is a spin-off out of Canada’s pre-eminent biological research organization, the National Research Council (NRC). PharmaGap’s unique research and drug development platform is a result of almost 10 years and $10 million of funded research by NRC scientists.